Tert-butyl 4-{5-[(prop-2-enamido)methyl]-1,2-oxazol-3-yl}piperidine-1-carboxylate
Structure Info
- Chemspace ID
- CSSB01911839873 (In-Stock Building Blocks)
- IUPAC Name
- tert-butyl 4-{5-[(prop-2-enamido)methyl]-1,2-oxazol-3-yl}piperidine-1-carboxylate
- Mol formula
- C17H25N3O4
- Mol weight
- 335 Da
- Catalog Number(s)
- BBLS01911839873, CSCR01911839873, EN300-45758081, Z3766086105, bbls01911839873
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.48
- Heavy atoms count
- 24
- Rotatable bond count
- 6
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.588
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of Tert-butyl 4-{5-[(prop-2-enamido)methyl]-1,2-oxazol-3-yl}piperidine-1-carboxylate (C17H25N3O4) - CSSB01911839873](/st/structure/200/72f04ca990b6a1ee0335181ca2b0f1c4/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNOC%2528CNC%2528%253DO%2529C%253DC%2529%253DC1.png "C17H25N3O4")
- Zoom the structure
- CSSB01911839873
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 912.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 955.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 999.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 1,042.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,086.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,127.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 3,147.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,667.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of tert-butyl 4-[5-(ethenesulfonamidomethyl)-1,2-oxazol-3-yl]piperidine-1-carboxylate - CSSB21332109982](/st/structure/200/ae5acdb68dd8165dd5c9e0a81e0b76b9/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNOC%2528CNS%2528%253DO%2529%2528%253DO%2529C%253DC%2529%253DC1.png)
![Chemical structure of tert-butyl 4-{5-[(2-chloroacetamido)methyl]-1,2-oxazol-3-yl}piperidine-1-carboxylate - CSSB01911839874](/st/structure/200/235021d58834683d6e773786a620a747/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNOC%2528CNC%2528%253DO%2529CCl%2529%253DC1.png)
![Chemical structure of N-[(3-cyclobutyl-1,2-oxazol-5-yl)methyl]prop-2-enamide - CSSB06786034854](/st/structure/200/3d274d2fc77ea0987ee845b965d9683b/C%253DCC%2528%253DO%2529NCc1cc%2528no1%2529C2CCC2.png)
![Chemical structure of N-[(3-cyclopentyl-1,2-oxazol-5-yl)methyl]prop-2-enamide - CSSB21332042119](/st/structure/200/1421db50374138fc5cce6f7cbef0d897/C%253DCC%2528%253DO%2529NCC1%253DCC%2528%253DNO1%2529C1CCCC1.png)
![Chemical structure of tert-butyl 4-{5-[(prop-2-enamido)methyl]-1,3,4-thiadiazol-2-yl}piperidine-1-carboxylate - CSSB21332085891](/st/structure/200/8f1f481cc95e02ff8c69d40b99d2a5a4/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNN%253DC%2528CNC%2528%253DO%2529C%253DC%2529S1.png)
![Chemical structure of N-[(3-cyclopropyl-1,2-oxazol-5-yl)methyl]prop-2-enamide - CSSB00119737983](/st/structure/200/591550e12274a746b023bfc9e1a4e11e/C%253DCC%2528%253DO%2529NCC1%253DCC%2528%253DNO1%2529C1CC1.png)
![Chemical structure of tert-butyl 4-{5-[(2-chloro-2-fluoroacetamido)methyl]-1,2-oxazol-3-yl}piperidine-1-carboxylate - CSSB21332120289](/st/structure/200/d71b3ea56d111e7d8fae8bdc5bd093a0/CC%2528C%2529%2528C%2529OC%2528%253DO%2529N1CCC%2528CC1%2529C1%253DNOC%2528CNC%2528%253DO%2529C%2528F%2529Cl%2529%253DC1.png)
